ANAB

Anaptysbio Stock Analysis

AI Rating

Neutral
  • Quality1/10
  • Growth↑ 8/10
  • Value↓ 1/10
Anaptysbio sales and earnings growth
ANAB Growth
Good
  • Revenue Y/Y↑ 121.59%
  • EPS Y/Y↑ 80.38%
  • FCF Y/Y↑ 104.04%
Anaptysbio gross and profit margin trends
ANAB Profitability
Neutral
  • Gross margin ↑ 100.00%
  • EPS margin↓ -11.50%
  • ROIC 5Y↓ -18.07%
Anaptysbio net debt vs free cash flow
ANAB Risk
Poor
  • Debt / Equity↑ 21.8
  • Debt / FCF↑ 6.6
  • Interest coverage↓ NA

Anaptysbio stock is less volatile than the overall market, so it's low risk. We give it a Poor risk rating.

↗ More Biotechnology stocks